These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

260 related items for PubMed ID: 24907382

  • 1. Diminished systemic and antigen-specific type 1, type 17, and other proinflammatory cytokines in diabetic and prediabetic individuals with latent Mycobacterium tuberculosis infection.
    Kumar NP, George PJ, Kumaran P, Dolla CK, Nutman TB, Babu S.
    J Infect Dis; 2014 Nov 15; 210(10):1670-8. PubMed ID: 24907382
    [Abstract] [Full Text] [Related]

  • 2. Coexistent Malnutrition Is Associated with Perturbations in Systemic and Antigen-Specific Cytokine Responses in Latent Tuberculosis Infection.
    Anuradha R, Munisankar S, Bhootra Y, Kumar NP, Dolla C, Kumaran P, Babu S.
    Clin Vaccine Immunol; 2016 Apr 15; 23(4):339-45. PubMed ID: 26865593
    [Abstract] [Full Text] [Related]

  • 3. Type 2 diabetes mellitus coincident with pulmonary tuberculosis is associated with heightened systemic type 1, type 17, and other proinflammatory cytokines.
    Kumar NP, Sridhar R, Banurekha VV, Jawahar MS, Fay MP, Nutman TB, Babu S.
    Ann Am Thorac Soc; 2013 Oct 15; 10(5):441-9. PubMed ID: 23987505
    [Abstract] [Full Text] [Related]

  • 4. Type 2 diabetes mellitus coincident with pulmonary or latent tuberculosis results in modulation of adipocytokines.
    Pavan Kumar N, Nair D, Banurekha VV, Dolla C, Kumaran P, Sridhar R, Babu S.
    Cytokine; 2016 Mar 15; 79():74-81. PubMed ID: 26771473
    [Abstract] [Full Text] [Related]

  • 5. Hyperglycaemia is inversely correlated with live M. bovis BCG-specific CD4+ T cell responses in Tanzanian adults with latent or active tuberculosis.
    Boillat-Blanco N, Tumbo AN, Perreau M, Amelio P, Ramaiya KL, Mganga M, Schindler C, Gagneux S, Reither K, Probst-Hensch N, Pantaleo G, Daubenberger C, Portevin D.
    Immun Inflamm Dis; 2018 Jun 15; 6(2):345-353. PubMed ID: 29642283
    [Abstract] [Full Text] [Related]

  • 6. Impaired Cytokine but Enhanced Cytotoxic Marker Expression in Mycobacterium tuberculosis-Induced CD8+ T Cells in Individuals With Type 2 Diabetes and Latent Mycobacterium tuberculosis Infection.
    Kumar NP, Moideen K, George PJ, Dolla C, Kumaran P, Babu S.
    J Infect Dis; 2016 Mar 01; 213(5):866-70. PubMed ID: 26486635
    [Abstract] [Full Text] [Related]

  • 7. Heterogeneity in the cytokine profile of tuberculosis - diabetes co-morbidity.
    Kumar NP, Moideen K, Nancy A, Viswanathan V, Shruthi BS, Sivakumar S, Natarajan M, Kornfeld H, Babu S.
    Cytokine; 2020 Jan 01; 125():154824. PubMed ID: 31472402
    [Abstract] [Full Text] [Related]

  • 8. Type 2 diabetes - Tuberculosis co-morbidity is associated with diminished circulating levels of IL-20 subfamily of cytokines.
    Kumar NP, Banurekha VV, Nair D, Kumaran P, Dolla CK, Babu S.
    Tuberculosis (Edinb); 2015 Dec 01; 95(6):707-712. PubMed ID: 26354610
    [Abstract] [Full Text] [Related]

  • 9. Decreased Frequencies of Gamma/Delta T Cells Expressing Th1/Th17 Cytokine, Cytotoxic, and Immune Markers in Latent Tuberculosis-Diabetes/Pre-Diabetes Comorbidity.
    Kathamuthu GR, Kumar NP, Moideen K, Menon PA, Babu S.
    Front Cell Infect Microbiol; 2021 Dec 01; 11():756854. PubMed ID: 34765568
    [Abstract] [Full Text] [Related]

  • 10. Expansion of pathogen-specific T-helper 1 and T-helper 17 cells in pulmonary tuberculosis with coincident type 2 diabetes mellitus.
    Kumar NP, Sridhar R, Banurekha VV, Jawahar MS, Nutman TB, Babu S.
    J Infect Dis; 2013 Sep 01; 208(5):739-48. PubMed ID: 23715661
    [Abstract] [Full Text] [Related]

  • 11. Anthelmintic Therapy Modifies the Systemic and Mycobacterial Antigen-Stimulated Cytokine Profile in Helminth-Latent Mycobacterium tuberculosis Coinfection.
    Anuradha R, Munisankar S, Bhootra Y, Dolla C, Kumaran P, Nutman TB, Babu S.
    Infect Immun; 2017 Apr 01; 85(4):. PubMed ID: 28167672
    [Abstract] [Full Text] [Related]

  • 12. Latent M. tuberculosis infection is associated with increased inflammatory cytokine and decreased suppressor of cytokine signalling (SOCS)-3 in the diabetic host.
    Masood KI, Irfan M, Masood Q, Yameen M, Jamil B, Ram N, Rao S, Rottenberg M, Hasan Z.
    Scand J Immunol; 2022 Apr 01; 95(4):e13134. PubMed ID: 34951048
    [Abstract] [Full Text] [Related]

  • 13. Modulation of pro- and anti-inflammatory cytokines in active and latent tuberculosis by coexistent Strongyloides stercoralis infection.
    George PJ, Pavan Kumar N, Jaganathan J, Dolla C, Kumaran P, Nair D, Banurekha VV, Shen K, Nutman TB, Babu S.
    Tuberculosis (Edinb); 2015 Dec 01; 95(6):822-828. PubMed ID: 26542223
    [Abstract] [Full Text] [Related]

  • 14. Coincident diabetes mellitus modulates Th1-, Th2-, and Th17-cell responses in latent tuberculosis in an IL-10- and TGF-β-dependent manner.
    Kumar NP, Moideen K, George PJ, Dolla C, Kumaran P, Babu S.
    Eur J Immunol; 2016 Feb 01; 46(2):390-9. PubMed ID: 26518995
    [Abstract] [Full Text] [Related]

  • 15. High body mass index is associated with heightened systemic and mycobacterial antigen - Specific pro-inflammatory cytokines in latent tuberculosis.
    Anuradha R, Munisankar S, Bhootra Y, Dolla C, Kumaran P, Babu S.
    Tuberculosis (Edinb); 2016 Dec 01; 101():56-61. PubMed ID: 27865399
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Comparison of interferon-γ-, interleukin (IL)-17- and IL-22-expressing CD4 T cells, IL-22-expressing granulocytes and proinflammatory cytokines during latent and active tuberculosis infection.
    Cowan J, Pandey S, Filion LG, Angel JB, Kumar A, Cameron DW.
    Clin Exp Immunol; 2012 Feb 01; 167(2):317-29. PubMed ID: 22236009
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Hyperglycemia modulates M1/M2 macrophage polarization in chronic diabetic patients with pulmonary tuberculosis infection.
    Panda S, Arora A, Luthra K, Mohan A, Vikram NK, Kumar Gupta N, Singh A.
    Immunobiology; 2024 Mar 01; 229(2):152787. PubMed ID: 38271857
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.